Allstate (NYSE:ALL) Stock Rating Reaffirmed by Keefe, Bruyette & Woods

Allstate (NYSE:ALL)‘s stock had its “outperform” rating restated by investment analysts at Keefe, Bruyette & Woods in a report issued on Friday, Benzinga reports. They currently have a $194.00 price target on the insurance provider’s stock. Keefe, Bruyette & Woods’ price target would indicate a potential upside of 20.86% from the stock’s previous close.

Several other equities analysts have also issued reports on the company. Roth Mkm boosted their price objective on Allstate from $175.00 to $200.00 and gave the company a “buy” rating in a research report on Monday, April 8th. Piper Sandler boosted their price objective on Allstate from $172.00 to $188.00 and gave the company an “overweight” rating in a research report on Monday, April 1st. StockNews.com lowered Allstate from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 3rd. HSBC raised Allstate from a “hold” rating to a “buy” rating and upped their price target for the stock from $158.00 to $190.00 in a research report on Thursday, March 28th. Finally, Morgan Stanley upped their price target on Allstate from $187.00 to $190.00 and gave the stock an “overweight” rating in a research report on Monday, April 15th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $174.88.

Allstate Stock Performance

Shares of NYSE:ALL opened at $160.51 on Friday. The stock has a market capitalization of $42.36 billion, a P/E ratio of 35.43, a P/E/G ratio of 1.55 and a beta of 0.50. Allstate has a 1-year low of $100.57 and a 1-year high of $177.37. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.48. The business has a 50-day moving average price of $166.53 and a two-hundred day moving average price of $159.39.

Allstate (NYSE:ALL) last posted its earnings results on Thursday, May 2nd. The insurance provider reported $5.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.11 by $1.02. The company had revenue of $15.26 billion during the quarter, compared to analyst estimates of $12.76 billion. Allstate had a return on equity of 14.44% and a net margin of 2.31%. The company’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same period in the previous year, the company earned ($1.30) EPS. Equities analysts predict that Allstate will post 14.99 earnings per share for the current year.

Insider Activity at Allstate

In related news, insider John E. Dugenske sold 31,000 shares of the stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total value of $5,276,200.00. Following the sale, the insider now owns 63,731 shares in the company, valued at approximately $10,847,016.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. SageView Advisory Group LLC bought a new position in Allstate during the 4th quarter worth $456,000. Rafferty Asset Management LLC increased its position in Allstate by 5.7% during the 4th quarter. Rafferty Asset Management LLC now owns 92,753 shares of the insurance provider’s stock worth $12,984,000 after buying an additional 4,987 shares during the period. Ellsworth Advisors LLC bought a new position in Allstate during the 4th quarter worth $4,312,000. SteelPeak Wealth LLC increased its position in Allstate by 175.2% during the 4th quarter. SteelPeak Wealth LLC now owns 15,682 shares of the insurance provider’s stock worth $2,209,000 after buying an additional 9,984 shares during the period. Finally, Lighthouse Investment Partners LLC bought a new position in Allstate during the 4th quarter worth $5,927,000. Institutional investors own 76.47% of the company’s stock.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.